Vidal, Gregory A., University of Tennessee West Cancer Center, United States
-
Vol 7, No 2 (2017) - Original Articles
A phase II trial of neoadjuvant doxorubicin plus cyclophosphamide followed by lapatinib plus docetaxel sequential with adjuvant trastuzumab for treatment of early HER2 positive breast cancers
Abstract PDF
Journal of Solid Tumors
ISSN 1925-4067(Print) ISSN 1925-4075(Online)
Copyright © Sciedu Press
To make sure that you can receive messages from us, please add the 'Sciedupress.com' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.